首页> 外文期刊>The Journal of Urology >Microsurgical spermatocelectomy: technique and outcomes of a novel surgical approach.
【24h】

Microsurgical spermatocelectomy: technique and outcomes of a novel surgical approach.

机译:显微手术精囊切除术:一种新的手术方法的技术和结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: A microsurgical approach to spermatocelectomy theoretically minimizes the risk of injury to the epididymis and testicular blood supply. We present the technique of microsurgical spermatocelectomy and report our perioperative and recurrence outcomes. MATERIALS AND METHODS: In a 15-year period 23 men with a total of 36 epididymal cystic masses underwent microsurgical resection with confirmation of spermatocele diagnosis by intraoperative identification of sperm in the cyst fluid. We reviewed pathology reports for resected epididymal tissue in the spermatocele specimen. Postoperative outcome measures included complications, sperm count changes, improvement in pain and fertility, and cyst recurrence. RESULTS: Mean spermatocele size was 5.0 cm (range 1 to 15). Common indications for surgery included pain in 35% of cases, infertility in 30% and the 2 conditions in 13%. A total of 13 patients (57%) underwent simultaneous procedures for concomitant varicocele and/or hydrocele with a mean overall surgical time of 152 minutes. A single scrotal hematoma managed conservatively was the only postoperative complication. There was no case of infection. Avoidance of inadvertent epididymal resection was shown by absent epididymal tissue in each of the 36 spermatocele pathology specimens. Also, no patient with preoperative and postoperative semen analyses available experienced a decreased sperm count, confirming the avoidance of iatrogenic epididymal tubule obstruction. At a mean followup of 17.3 months no man had cyst recurrence or testicular atrophy and all with preoperative pain reported improvement. One patient with preoperative infertility achieved pregnancy 12 months after surgery. CONCLUSIONS: Microsurgical spermatocelectomy is safe and effective with a minimal risk of epididymal injury, testicular atrophy and recurrence.
机译:目的:精子切除术的显微外科手术理论上可将附睾和睾丸供血的损伤风险降至最低。我们介绍了显微外科精囊切除术的技术,并报告了围手术期和复发的结果。材料与方法:在15年的时间里,对23名总共36个附睾囊性肿块的男性进行了显微手术切除,并通过术中鉴定囊液中的精子来确诊精子囊肿。我们审查了精子囊肿标本中切除的附睾组织的病理报告。术后结果指标包括并发症,精子数量变化,疼痛和生育力改善以及囊肿复发。结果:平均精子囊肿大小为5.0厘米(范围1至15)。手术的常见适应症包括35%的患者疼痛,30%的不育症和13%的两种疾病。总共13例患者(57%)同时接受了精索静脉曲张和/或鞘膜积液的手术,平均总手术时间为152分钟。保守治疗单个阴囊血肿是术后唯一的并发症。没有感染病例。 36个精囊膨出病理标本中的每个均没有附睾组织,这表明可以避免意外的附睾切除。而且,没有可进行术前和术后精液分析的患者精子数量减少,这证实了避免了医源性附睾小管阻塞。在平均17.3个月的随访中,没有人出现囊肿复发或睾丸萎缩,并且所有术前疼痛均得到了改善。一名术前不孕患者在手术后12个月怀孕。结论:显微外科精囊切除术安全有效,附睾损伤,睾丸萎缩和复发的风险最小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号